NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-7.48 Cr | ₹-21 Cr | ₹-2.80 Cr | ₹-12 Cr | ₹116 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NECTAR LIFESCIENCES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-7.48 Cr |
Mar2023 | ₹-21 Cr |
Mar2022 | ₹-2.80 Cr |
Mar2021 | ₹-12 Cr |
Mar2020 | ₹116 Cr |
How is Deferred Tax Assets / Liabilities of NECTAR LIFESCIENCES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-7.48 Cr | Negative | |
Mar2023 | ₹-21 Cr | Negative | |
Mar2022 | ₹-2.80 Cr | Negative | |
Mar2021 | ₹-12 Cr | Negative | |
Mar2020 | ₹116 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹721.8 Cr | -14.7% | -16.4% | -5.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,363.0 Cr | -2.8% | -3.6% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,396.0 Cr | -2.5% | 1.5% | 59.1% | Stock Analytics | |
CIPLA | ₹117,088.0 Cr | -1.5% | 0.2% | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,458.0 Cr | -1.6% | -9.2% | -4.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,002.4 Cr | -7.4% | -5.1% | 9.9% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | -14.7% |
-16.4% |
-5.7% |
SENSEX | -2.7% |
-0.4% |
6.4% |
You may also like the below Video Courses